1. Home
  2. OVLY vs VYGR Comparison

OVLY vs VYGR Comparison

Compare OVLY & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oak Valley Bancorp (CA)

OVLY

Oak Valley Bancorp (CA)

HOLD

Current Price

$31.69

Market Cap

252.2M

Sector

Finance

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.76

Market Cap

226.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVLY
VYGR
Founded
1990
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
252.2M
226.8M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
OVLY
VYGR
Price
$31.69
$3.76
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.00
AVG Volume (30 Days)
12.7K
516.9K
Earning Date
01-23-2026
11-10-2025
Dividend Yield
1.94%
N/A
EPS Growth
N/A
N/A
EPS
2.84
N/A
Revenue
$79,783,000.00
$31,316,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$71.78
P/E Ratio
$10.89
N/A
Revenue Growth
2.98
N/A
52 Week Low
$22.70
$2.65
52 Week High
$31.45
$5.96

Technical Indicators

Market Signals
Indicator
OVLY
VYGR
Relative Strength Index (RSI) 66.81 39.01
Support Level $30.03 $3.81
Resistance Level $30.72 $4.24
Average True Range (ATR) 0.72 0.21
MACD 0.03 -0.02
Stochastic Oscillator 82.49 6.73

Price Performance

Historical Comparison
OVLY
VYGR

About OVLY Oak Valley Bancorp (CA)

Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: